1 year return (CAGR)
-30.29%
Janux Therapeutics Inc Exchange (NASDAQ, USD)
JANX
17.01
+0.42 (+2.53%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
17.71%
5 year return (CAGR)
-9.72%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.04B
Price/Sales
32.62
Ent value
1.09B
Price/Book
1.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
19.20%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.86 |
| Daily high | 17.14 |
| Daily low | 16.57 |
| Daily Volume | 702K |
| All-time high | 66.83 |
| 1y analyst estimate | 36.24 |
| Beta | 2.51 |
| EPS (TTM) | -1.63 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 Mar 2026 |
Downside potential
Loading...
Downside potential data
| JANX | S&P500 | |
| Current price drop from All-time high | -74.55% | -0.56% |
| Highest price drop | -83.14% | -56.47% |
| Date of highest drop | 9 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -53.28% | -10.68% |
| Avg time to new high | 55 days | 12 days |
| Max time to new high | 643 days | 1805 days |
News
